Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer
Clinical trial NCT01433172 · COMPLETED
Trial details
- NCT number
- NCT01433172
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-26
- Primary completion
- 2016-01-31
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.